CSIMarket


Boston Scientific Corporation  (NYSE: BSX)
Other Ticker:  
 

Boston Scientific Corporation

BSX's Fundamental analysis








Looking into Boston Scientific growth rates, revenue grew by 19.34 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 523

Medical Equipment & Supplies industry recorded growth of revenues by 1.71 %

Boston Scientific's net profit decreased by -7.14 % in III. Quarter 2024 year on year, to $468 millions.

More on BSX's Growth


Boston Scientific
current PE on trailing twelve month basis is below Medical Equipment & Supplies industry average.

Boston Scientific PEG ratio is at 1.93 Company is currently trading with Price to Cash flow multiple of 96.73 in trailing twelve-month period.
Company
84.11
PE TTM   
Industry
152.51
PE TTM    
Company's Price to Sales ratio is at 9.22.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.53.


More on BSX's Valuation
 
 Total Debt (Millions $) 10,885
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 331,479
 Net Income/Employee (TTM) $ 37,229
 Receivable Turnover (TTM) 6.75
 Tangible Book Value (Per Share $) 0.11

Boston Scientific
current PE on trailing twelve month basis is below Medical Equipment & Supplies industry average.

Boston Scientific PEG ratio is at 1.93 Company is currently trading with Price to Cash flow multiple of 96.73 in trailing twelve-month period.
Company
84.11
PE TTM   
Industry
152.51
PE TTM    
Company's Price to Sales ratio is at 9.22.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.53.

Boston Scientific Price to Book Ratio is at 7 higher than Industry Avg. of -192.06, and higher than S&P 500 Avg. of 0.01

More on BSX's Valuation

  Market Capitalization (Millions $) 146,747
  Shares Outstanding (Millions) 1,487
  Employees 48,000
  Revenues (TTM) (Millions $) 15,911
  Net Income (TTM) (Millions $) 1,787
  Cash Flow (TTM) (Millions $) 1,517
  Capital Exp. (TTM) (Millions $) -780
  Total Debt (Millions $) 10,885
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 331,479
  Net Income/Employee(TTM) $ 37,229
  Receivable Turnover Ratio (TTM) 6.75
  Tangible Book Value (Per Share $) 0.11

  Market Capitalization (Millions $) 146,747
  Shares Outstanding (Millions) 1,487
  Employees 48,000
  Revenues (TTM) (Millions $) 15,911
  Net Income (TTM) (Millions $) 1,787
  Cash Flow (TTM) (Millions $) 1,517
  Capital Exp. (TTM) (Millions $) -780


    BSX's Profitability Comparisons
Boston Scientific achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 17.42 % from 12.62 % in II. Quarter.

Boston Scientific net profit margin of 11.12 % is currently ranking no. 32 in Medical Equipment & Supplies industry, ranking no. 106 in Healthcare sector and number 1212 in S&P 500.


Profitability by Segment
Total 11.12 %



  Ratio
   Capital Ratio (MRQ) 1.48
  Total Debt to Equity (MRQ) 0.52
  Tangible Leverage Ratio (MRQ) 91.07
  Asset Turnover Ratio (TTM) 0.48
  Inventory Turnover Ratio (TTM) 1.9



Boston Scientific achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 17.42 % from 12.62 % in II. Quarter.

Boston Scientific net profit margin of 11.12 % is currently ranking no. 32 in Medical Equipment & Supplies industry, ranking no. 106 in Healthcare sector and number 1212 in S&P 500.

More on BSX's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com